# Hospital and Health System Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/hospital-and-health-system-compounding-under-section-503a-of-the-federal-food-drug-and-cosmetic-act-guidance-for-industry/e0535821-7435-45f2-b7a6-0f238fd5d3ed > FDA guidance document: Hospital and Health System Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry. Issue date: October 06, 2021. Get complete insights and analysis. --- ## Details - Title: Hospital and Health System Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry - Communication Type: Guidance Document - Product Type: drugs - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2021-10-06 - Last Changed: 2021-10-06 - Docket Number: FDA-2016-D-0271 ## Related Documents - [Establishing Impurity Specifications for Antibiotics](https://www.globalkeysolutions.net/guidances/guidance-document/establishing-impurity-specifications-for-antibiotics/5bb8badb-7c32-4b76-bfc9-bbb8ab55fb84) - [Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/formal-dispute-resolution-and-administrative-hearings-of-final-administrative-orders-under-section-505g-of-the-federal-food-drug-and-cosmetic-act/17bebcf8-b43d-4abb-89dd-98ff77692884) - [Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/prohibition-on-wholesaling-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/dd86fdd5-6650-410b-8062-44da26860675)